This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $1,712.58 firm fixed price contract is for the supply of 4,561,953,593 units of the pharmaceutical product Telmisartan 80 mg Tablet 30s. The contract has an ultimate completion date of August 28, 2023 and was awarded on August 26, 2023. There is no set-aside designation for this award. Amerisourcebergen, a leading...
This federal contract award, valued at $1,117.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,013,582 units of telmisartan 80 mg tablets in 30-count packages. The contract is a delivery order with a firm fixed-price pricing type and has an ultimate completion date of April 24, 2025. It is not designated as a set-aside contract, indicating open...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,093,125 units of the prescription drug Telmisartan 80 mg tablets in 30-count bottles. The contract is a firm-fixed price delivery order with a ceiling value of $4,833.69 and a period of performance through October 15, 2024. There is no set-aside designation for this award. Amerisourcebergen has a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,221.93 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets. The contract has an ultimate completion date of September 23, 2024 and does not utilize a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
This federal contract award, with ID SPE2DB20D3104|SPE2DB24FV8S0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp Corporate Office Division. The $6,442.14 delivery order is for the supply of 4,565,377,134 units of the pharmaceutical product Telmisartan 80 mg tablets. The contract has a firm fixed price and does not utilize any set-asides. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 80 mg tablets. The $1,987.92 firm-fixed-price contract has a ceiling value of $1,987.92 and an ultimate completion date of July 31, 2024. This order is not set aside for any specific business category. Amerisourcebergen Drug Corp's Corporate Office Division holds several Indefinite Delivery Contracts (IDCs) with the DLA and other...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4,564,322,194 tablets of the drug telmisartan 40 mg. The $11,640.08 contract has an ultimate completion date of April 19, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,065.92 firm-fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a hypertension medication, to support military treatment facilities and other government healthcare programs. The contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,323.36 firm fixed-price delivery order is for the supply of 4566861313 TELMISARTAN 80 MG TABLET 30S, with a performance period ending on January 8, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,630.20, is for the delivery of telmisartan 80 mg tablets. It is a firm fixed-price delivery order contract with an ultimate completion date of April 2, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp, the prime contractor, has a significant Indefinite Delivery...